Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysis

ObjectiveWith the prevalence of next-generation sequencing (NGS) technology, a large number of long non-coding RNAs (lncRNAs) have attracted tremendous attention and have been the topic of extensive research on gastric cancer (GC). It was revealed that lncRNAs not only participate in the transductio...

Full description

Bibliographic Details
Main Authors: Jian Li, Yanyan Zhang, Qingyu Xu, Yaqiong Zhang, Songhua Bei, Ying Ding, Xiaohong Zhang, Li Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1058028/full
_version_ 1811314438634995712
author Jian Li
Yanyan Zhang
Qingyu Xu
Yaqiong Zhang
Songhua Bei
Ying Ding
Xiaohong Zhang
Li Feng
author_facet Jian Li
Yanyan Zhang
Qingyu Xu
Yaqiong Zhang
Songhua Bei
Ying Ding
Xiaohong Zhang
Li Feng
author_sort Jian Li
collection DOAJ
description ObjectiveWith the prevalence of next-generation sequencing (NGS) technology, a large number of long non-coding RNAs (lncRNAs) have attracted tremendous attention and have been the topic of extensive research on gastric cancer (GC). It was revealed that lncRNAs not only participate in the transduction of various signaling pathways, thus influencing GC genesis and development, but also have the potential for GC diagnosis. Therefore, we aimed to conduct a meta-analysis of previous studies on GC.Materials and methodsAn electronic search was made before August 2021 on databases including PubMed, Embase, and Web of Science. Relevant articles that compare lncRNA expression in GC patients and healthy controls were summarized. We conducted a meta-analysis with the objective of evaluating the ability of lncRNAs in diagnosing GC.ResultsA total of 40 original research studies including 6,772 participants were discussed in this meta-analysis. The overall sensitivity, specificity, and the area under the curve (AUC) were 0.78 (95% CI: 0.75–0.81), 0.79 (95% CI: 0.74–0.83), and 0.85 (95% CI: 0.81–0.87), respectively. The value of pooled diagnostic odds ratios (DORs) was 13.00 (95% CI: 10.00–17.00).ConclusionsThis meta-analysis revealed that serum or plasma lncRNAs have high sensitivity and specificity, which makes lncRNAs clinically feasible in diagnosing GC. The results from this meta-analysis demonstrated that peripheral blood lncRNAs may become novel noninvasive biomarkers in the foreseeable future. At the same time, it should be noted that a greater number of blood samples and more evidence from rigorous multicenter clinical studies are necessary to justify their applicability as cancer biomarkers.
first_indexed 2024-04-13T11:12:50Z
format Article
id doaj.art-fb1db21902f7444ca96cb8f947a7eba6
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-13T11:12:50Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-fb1db21902f7444ca96cb8f947a7eba62022-12-22T02:49:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.10580281058028Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysisJian LiYanyan ZhangQingyu XuYaqiong ZhangSonghua BeiYing DingXiaohong ZhangLi FengObjectiveWith the prevalence of next-generation sequencing (NGS) technology, a large number of long non-coding RNAs (lncRNAs) have attracted tremendous attention and have been the topic of extensive research on gastric cancer (GC). It was revealed that lncRNAs not only participate in the transduction of various signaling pathways, thus influencing GC genesis and development, but also have the potential for GC diagnosis. Therefore, we aimed to conduct a meta-analysis of previous studies on GC.Materials and methodsAn electronic search was made before August 2021 on databases including PubMed, Embase, and Web of Science. Relevant articles that compare lncRNA expression in GC patients and healthy controls were summarized. We conducted a meta-analysis with the objective of evaluating the ability of lncRNAs in diagnosing GC.ResultsA total of 40 original research studies including 6,772 participants were discussed in this meta-analysis. The overall sensitivity, specificity, and the area under the curve (AUC) were 0.78 (95% CI: 0.75–0.81), 0.79 (95% CI: 0.74–0.83), and 0.85 (95% CI: 0.81–0.87), respectively. The value of pooled diagnostic odds ratios (DORs) was 13.00 (95% CI: 10.00–17.00).ConclusionsThis meta-analysis revealed that serum or plasma lncRNAs have high sensitivity and specificity, which makes lncRNAs clinically feasible in diagnosing GC. The results from this meta-analysis demonstrated that peripheral blood lncRNAs may become novel noninvasive biomarkers in the foreseeable future. At the same time, it should be noted that a greater number of blood samples and more evidence from rigorous multicenter clinical studies are necessary to justify their applicability as cancer biomarkers.https://www.frontiersin.org/articles/10.3389/fonc.2022.1058028/fullgastric cancerlncRNAdiagnosissystematic reviewmeta - analysis
spellingShingle Jian Li
Yanyan Zhang
Qingyu Xu
Yaqiong Zhang
Songhua Bei
Ying Ding
Xiaohong Zhang
Li Feng
Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysis
Frontiers in Oncology
gastric cancer
lncRNA
diagnosis
systematic review
meta - analysis
title Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysis
title_full Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysis
title_fullStr Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysis
title_full_unstemmed Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysis
title_short Diagnostic value of circulating lncRNAs for gastric cancer: A systematic review and meta-analysis
title_sort diagnostic value of circulating lncrnas for gastric cancer a systematic review and meta analysis
topic gastric cancer
lncRNA
diagnosis
systematic review
meta - analysis
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1058028/full
work_keys_str_mv AT jianli diagnosticvalueofcirculatinglncrnasforgastriccancerasystematicreviewandmetaanalysis
AT yanyanzhang diagnosticvalueofcirculatinglncrnasforgastriccancerasystematicreviewandmetaanalysis
AT qingyuxu diagnosticvalueofcirculatinglncrnasforgastriccancerasystematicreviewandmetaanalysis
AT yaqiongzhang diagnosticvalueofcirculatinglncrnasforgastriccancerasystematicreviewandmetaanalysis
AT songhuabei diagnosticvalueofcirculatinglncrnasforgastriccancerasystematicreviewandmetaanalysis
AT yingding diagnosticvalueofcirculatinglncrnasforgastriccancerasystematicreviewandmetaanalysis
AT xiaohongzhang diagnosticvalueofcirculatinglncrnasforgastriccancerasystematicreviewandmetaanalysis
AT lifeng diagnosticvalueofcirculatinglncrnasforgastriccancerasystematicreviewandmetaanalysis